Suppr超能文献

单次高强度聚焦超声治疗大型良性甲状腺结节

Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.

作者信息

Lang Brian Hung-Hin, Woo Yu-Cho, Chiu Keith Wan-Hang

机构信息

1 Department of Surgery, The University of Hong Kong , Hong Kong SAR, China .

2 Department of Medicine, The University of Hong Kong , Hong Kong SAR, China .

出版信息

Thyroid. 2017 May;27(5):714-721. doi: 10.1089/thy.2016.0664. Epub 2017 Mar 22.

Abstract

BACKGROUND

High-intensity focused ultrasound (HIFU) is a new promising thermal ablation technique for treating benign thyroid nodules, but its effectiveness in larger-sized nodules has been less well described. The present study aimed to evaluate the treatment efficacy (i.e., extent of shrinkage at six months) of large-sized benign thyroid nodules by ultrasound (USG)-guided HIFU ablation.

MATERIALS AND METHODS

After ethics approval, all consecutive patients who underwent HIFU ablation of a symptomatic benign thyroid nodule with six or more months of follow-up were analyzed. Treated nodules were categorized according to their pre-ablation volume (group I: <10 mL; groups II: 10-30 mL; group III: >30 mL). After treatment, the nodule volume was measured by USG at one week, one month, three months, and six months. Total energy delivered to each nodule (in kJ) and the time taken (in minutes) for that delivery were automatically recorded. The primary outcome was a change in nodule volume after six months, where percentage nodule volume change was calculated as (baseline volume - volume at six months)/(baseline volume) × 100. Ablation success was defined as >50% volume reduction.

RESULTS

Seventy-three nodules were treated successfully and followed for ≥6 months. The overall median six-month volume reduction was 68.3% (range 22.77-96.50%). At six months, group III had a significantly less volume shrinkage than group I (48.1% vs. 77.6%; p < 0.001) and group II (48.1% vs. 67.9%; p = 0.002). Also, the proportion of ablation success at six months in group III was significantly less than in the other two groups (p < 0.001). Pre-ablation nodule volume >30 mL (odds ratio = 7.813 [confidence interval 1.908-32.258]; p = 0.004) and lower total energy per nodule volume (odds ratio = 3.313 [confidence interval 1.113-9.688]; p = 0.029) were significant factors for less ablation success.

CONCLUSIONS

Single-session HIFU ablation was highly effective in causing shrinkage of benign thyroid nodules at six months, but the extent of shrinkage for larger-sized nodules (>30 mL) was noticeably less than that of smaller-sized nodules. Both pre-ablation nodule volume and total energy per nodule volume were significant determinants of ablation success. For larger-sized nodules, additional HIFU treatment three to six months after initial treatment might be preferred over sequential treatment within the same session.

摘要

背景

高强度聚焦超声(HIFU)是一种用于治疗良性甲状腺结节的新型且有前景的热消融技术,但对于较大尺寸结节其有效性的描述较少。本研究旨在通过超声(USG)引导下的HIFU消融评估大尺寸良性甲状腺结节的治疗效果(即六个月时的缩小程度)。

材料与方法

经伦理批准后,对所有接受有症状良性甲状腺结节HIFU消融且随访六个月或更长时间的连续患者进行分析。根据消融前体积对治疗的结节进行分类(I组:<10 mL;II组:10 - 30 mL;III组:>30 mL)。治疗后,在一周、一个月、三个月和六个月时通过USG测量结节体积。自动记录传递到每个结节的总能量(以kJ为单位)以及传递该能量所需的时间(以分钟为单位)。主要结局是六个月后结节体积的变化,其中结节体积变化百分比计算为(基线体积 - 六个月时的体积)/(基线体积)×100。消融成功定义为体积缩小>50%。

结果

73个结节成功接受治疗并随访≥6个月。总体六个月体积缩小中位数为68.3%(范围22.77 - 96.50%)。六个月时,III组的体积缩小明显小于I组(48.1%对77.6%;p < 0.001)和II组(48.1%对67.9%;p = 0.002)。此外,III组六个月时的消融成功率明显低于其他两组(p < 0.001)。消融前结节体积>30 mL(优势比 = 7.813 [置信区间1.908 - 32.258];p = 0.004)和每结节体积的总能量较低(优势比 = 3.313 [置信区间1.113 - 9.688];p = 0.029)是消融成功率较低的重要因素。

结论

单次HIFU消融在六个月时能有效使良性甲状腺结节缩小,但较大尺寸结节(>30 mL)的缩小程度明显小于较小尺寸结节。消融前结节体积和每结节体积的总能量均是消融成功的重要决定因素。对于较大尺寸结节,在初始治疗后三至六个月进行额外的HIFU治疗可能比在同一次治疗中进行序贯治疗更可取。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验